Cardioprotective Effect of Dexrazoxane in Patients with HER2-Positive Breast Cancer Who Receive Anthracycline Based Adjuvant Chemotherapy Followed by Trastuzumab

PURPOSE: We intended to determine whether dexrazoxane (DZR) is cardioprotective during administration of adjuvant anthracycline-based chemotherapy followed by a 1-year trastuzumab treatment. METHODS: The medical records of 228 patients who underwent surgical resection and received adjuvant chemother...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Breast Cancer
Autori principali: Kim, In-Ho, Lee, Ji Eun, Youn, Ho-Joong, Song, Byung Joo, Chae, Byung Joo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Breast Cancer Society 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378583/
https://ncbi.nlm.nih.gov/pubmed/28382098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2017.20.1.82
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi